BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25694385)

  • 1. Selective inhibitors of glutathione transferase P1 with trioxane structure as anticancer agents.
    Bräutigam M; Teusch N; Schenk T; Sheikh M; Aricioglu RZ; Borowski SH; Neudörfl JM; Baumann U; Griesbeck AG; Pietsch M
    ChemMedChem; 2015 Apr; 10(4):629-39. PubMed ID: 25694385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases.
    Federici L; Lo Sterzo C; Pezzola S; Di Matteo A; Scaloni F; Federici G; Caccuri AM
    Cancer Res; 2009 Oct; 69(20):8025-34. PubMed ID: 19808963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrobenzoxadiazole-based GSTP1-1 inhibitors containing the full peptidyl moiety of (pseudo)glutathione.
    Luisi G; Mollica A; Carradori S; Lenoci A; De Luca A; Caccuri AM
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):924-30. PubMed ID: 26329912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1.
    Musdal Y; Hegazy UM; Aksoy Y; Mannervik B
    Chem Biol Interact; 2013 Sep; 205(1):53-62. PubMed ID: 23769903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate.
    Cacciatore I; Caccuri AM; Cocco A; De Maria F; Di Stefano A; Luisi G; Pinnen F; Ricci G; Sozio P; Turella P
    Amino Acids; 2005 Nov; 29(3):255-61. PubMed ID: 16082503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Inhibition of Human Placental Glutathione S-Transferase by 3-Arylcoumarin Derivatives.
    Alparslan MM; Danış Ö
    Arch Pharm (Weinheim); 2015 Sep; 348(9):635-42. PubMed ID: 26205366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.
    Singh S
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):1-15. PubMed ID: 25143300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione transferases and development of new principles to overcome drug resistance.
    Sau A; Pellizzari Tregno F; Valentino F; Federici G; Caccuri AM
    Arch Biochem Biophys; 2010 Aug; 500(2):116-22. PubMed ID: 20494652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glutathione transferases in the mechanism of brostallicin activation.
    Pezzola S; Antonini G; Geroni C; Beria I; Colombo M; Broggini M; Marchini S; Mongelli N; Leboffe L; MacArthur R; Mozzi AF; Federici G; Caccuri AM
    Biochemistry; 2010 Jan; 49(1):226-35. PubMed ID: 19950984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure--activity relationship of new cytotoxic agents targeting human glutathione-S-transferases.
    Rotili D; De Luca A; Tarantino D; Pezzola S; Forgione M; Morozzo Della Rocca B; Falconi M; Mai A; Caccuri AM
    Eur J Med Chem; 2015 Jan; 89():156-71. PubMed ID: 25462236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
    Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
    J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione transferases as targets for cancer therapy.
    Ruzza P; Rosato A; Rossi CR; Floreani M; Quintieri L
    Anticancer Agents Med Chem; 2009 Sep; 9(7):763-77. PubMed ID: 19538171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
    Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R
    Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoenzyme- and allozyme-specific inhibitors: 2,2'-dihydroxybenzophenones and their carbonyl N-analogues that discriminate between human glutathione transferase A1-1 and P1-1 allozymes.
    Pouliou FM; Thireou TN; Eliopoulos EE; Tsoungas PG; Labrou NE; Clonis YD
    Chem Biol Drug Des; 2015 Nov; 86(5):1055-63. PubMed ID: 25891019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclopentenone prostaglandins with dienone structure promote cross-linking of the chemoresistance-inducing enzyme glutathione transferase P1-1.
    Sánchez-Gómez FJ; Díez-Dacal B; Pajares MA; Llorca O; Pérez-Sala D
    Mol Pharmacol; 2010 Oct; 78(4):723-33. PubMed ID: 20631055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
    Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
    Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chalcone derivatives inhibit glutathione S-transferase P1-1 activity: insights into the interaction mode of alpha, beta-unsaturated carbonyl compounds.
    Wang J; Wang S; Song D; Zhao D; Sha Y; Jiang Y; Jing Y; Cheng M
    Chem Biol Drug Des; 2009 May; 73(5):511-4. PubMed ID: 19323653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human glutathione S-transferases by curcumin and analogues.
    Appiah-Opong R; Commandeur JN; Istyastono E; Bogaards JJ; Vermeulen NP
    Xenobiotica; 2009 Apr; 39(4):302-11. PubMed ID: 19350453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of glutathione transferase P1-1 bound to a platinum(IV)-based anticancer compound reveal the molecular basis of its activation.
    Parker LJ; Italiano LC; Morton CJ; Hancock NC; Ascher DB; Aitken JB; Harris HH; Campomanes P; Rothlisberger U; De Luca A; Lo Bello M; Ang WH; Dyson PJ; Parker MW
    Chemistry; 2011 Jul; 17(28):7806-16. PubMed ID: 21681839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling.
    Burg D; Riepsaame J; Pont C; Mulder G; van de Water B
    Biochem Pharmacol; 2006 Jan; 71(3):268-77. PubMed ID: 16337611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.